Best for
All-rounder
How to buy Ayala Pharmaceuticals shares | $12.14
Own Ayala Pharmaceuticals shares in just a few minutes. Share price changes are updated daily.
Ayala Pharmaceuticals, Inc (AYLA) is a leading biotechnology business based in the US. It opened the day at $12.29 after a previous close of $12.21. During the day the price has varied from a low of $11.7 to a high of $12.4. The latest price was $12.14 (25 minute delay). Ayala Pharmaceuticals is listed on the NASDAQ and employs 31 staff. All prices are listed in US Dollars.
How to buy shares in Ayala Pharmaceuticals
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: AYLA in this case.
- Research Ayala Pharmaceuticals shares. The platform should provide the latest information available.
- Buy your Ayala Pharmaceuticals shares. It's that simple.
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
What's in this guide?
- Can I buy shares in Ayala Pharmaceuticals?
- Ayala Pharmaceuticals shares summary
- Compare share dealing platforms
- Is Ayala Pharmaceuticals stock a buy or sell?
- Ayala Pharmaceuticals performance over time
- Can I short Ayala Pharmaceuticals shares?
- Ayala Pharmaceuticals's financials
- Does Ayala Pharmaceuticals pay a dividend?
- Other common questions
Ayala Pharmaceuticals share price
Use our graph to track the performance of AYLA stocks over time.Ayala Pharmaceuticals shares at a glance
Information last updated 2020-10-06.
| Open | $12.29 |
|---|---|
| High | $12.4 |
| Low | $11.7 |
| Close | $12.14 |
| Previous close | $12.21 |
| Change | $-0.07 |
| Change % | -0.573% |
| Volume | 5,121 |
Information last updated 2020-12-27.
| 52-week range | $8.62 - $16.5 |
|---|---|
| 50-day moving average | $10.8721 |
| 200-day moving average | $11.6628 |
| Wall St. target price | $21.6 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
Invest in Ayala Pharmaceuticals shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy Ayala Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Ayala Pharmaceuticals price performance over time
Historical closes compared with the last close of $12.14
| 1 week (2021-01-08) | -3.68% |
|---|---|
| 1 month (2020-12-18) | 5.11% |
| 3 months (2020-10-16) | -7.68% |
| 6 months (2020-07-17) | -2.88% |
Ayala Pharmaceuticals financials
| Revenue TTM | $3.1 million |
|---|---|
| Gross profit TTM | $1 million |
| Return on assets TTM | -46.93% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Market capitalisation | $150.1 million |
TTM: trailing 12 months
How to short and sell Ayala Pharmaceuticals shares
- Create a CFD or spread betting account.
- Search for the stock code. E.g. "AYLA.US"
- Choose your position size.
- Select "sell" rather than "buy".
- Confirm your position and keep tabs on it. You may wish to set limits on your position.
There are currently 15,707 Ayala Pharmaceuticals shares held short by investors – that's known as Ayala Pharmaceuticals's "short interest". This figure is 23.9% up from 12,678 last month.
There are a few different ways that this level of interest in shorting Ayala Pharmaceuticals shares can be evaluated.
Ayala Pharmaceuticals's "short interest ratio" (SIR)
Ayala Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Ayala Pharmaceuticals shares currently shorted divided by the average quantity of Ayala Pharmaceuticals shares traded daily (recently around 16027.551020408). Ayala Pharmaceuticals's SIR currently stands at 0.98. In other words for every 100,000 Ayala Pharmaceuticals shares traded daily on the market, roughly 980 shares are currently held short.
However Ayala Pharmaceuticals's short interest can also be evaluated against the total number of tradable Ayala Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Ayala Pharmaceuticals's short interest could be expressed as 0.0025% of the tradable shares (for every 100,000 tradable Ayala Pharmaceuticals shares, roughly 3 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Ayala Pharmaceuticals.
Find out more about how you can short Ayala Pharmaceuticals stock.
Ayala Pharmaceuticals share dividends
We're not expecting Ayala Pharmaceuticals to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
Ayala Pharmaceuticals overview
Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, which is an intravenous injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, an oral injectable small molecule GSI that is in Phase I clinical trial for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was founded in 2017 and is based in Rehovot, Israel.
Frequently asked questions
More guides on Finder
-
How to invest in the Bombay Stock Exchange (BSE) from the UK
Find the cheapest and easiest ways to invest in Asia’s oldest stock exchange.
-
How to buy Transportation and Logistics Systems shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to invest in the Tokyo Stock Exchange from the UK
Find out the cheapest way to buy shares on Asia’s largest stock exchange.
-
How to invest in the Shanghai Stock Exchange (SSE) from the UK
Here’s the cheapest and easiest ways to invest in the world’s 4th-largest stock exchange.
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ask an Expert